ALEXANDRIA, Va. – Kevin Fitzpatrick will step down from his role as Chief Executive Officer of CancerLinQ LLC, a wholly owned non-profit subsidiarity of the American Society of Clinical Oncology (ASCO), on April 13 to pursue a new opportunity outside of ASCO. Richard L. Schilsky, MD, Chief Medical Officer (CMO) of ASCO, will serve as interim CEO. CancerLinQ LLC will initiate a global search for a permanent CEO to oversee the continued expansion and implementation of CancerLinQ®, ASCO’s big data platform designed to improve the quality of care for people with cancer.
Linda D. Bosserman, MD, FACP, FASCO, has been named Editor-in-Chief of the Journal of Oncology Practice (JOP), a publication of the American Society of Clinical Oncology (ASCO). Dr. Bosserman is a recognized leader in cancer care delivery with a deep understanding of the issues impacting all types of oncology practices.
A new study suggests that a large percentage of adolescents and young adults (AYAs) who have been treated for cancer do not seek follow-up care after their primary treatment ends, despite its importance for long-term health. AYA cancer survivors are at increased risk for heart problems, infertility, and secondary cancers from cancer treatment.
CancerLinQ LLC and the American College of Medical Genetics and Genomics (ACMG), the medical specialty society for clinical and laboratory genetics professionals, have entered into a programmatic collaboration. CancerLinQ®, the American Society of Clinical Oncology’s (ASCO) health information technology platform designed by oncologists for oncologists to leverage the power of big data to help improve the quality of care for patients with cancer, will benefit from the knowledge and expertise of ACMG leadership and members.
ALEXANDRIA, Va. – The American Society of Clinical Oncology, Inc. (ASCO®) has announced that the first three practices in Spain have received Quality Oncology Practice Initiative (QOPI®) certification through QOPI Certification Program™, LLC (QCP). The accreditations were given today at the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain.
The American Society of Clinical Oncology (ASCO) today issued a position statement aimed at contributing to the national dialogue on rising cancer drug prices. The statement, which asserts that any solutions must also preserve patients' access to care and foster innovation, analyzes a wide array of options and recommends that a panel of stakeholders be established to determine which proposals will be effective and develop a uniform approach for assessing the value of drugs.
ALEXANDRIA, Va. -- CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology (ASCO®), has announced that Santa Clara Valley Medical Center (SCVMC) in San Jose, Calif. has signed an agreement to participate in the CancerLinQ® platform.
ALEXANDRIA, Va. — Today, the American Society of Clinical Oncology, Inc. (ASCO®) announced that Instituto de Oncologia do Vale (IOV) has become the first practice in Brazil to receive Quality Oncology Practice Initiative (QOPI®) certification through QOPI Certification Program, LLC (QCP). IOV is the second international practice to achieve this milestone in demonstrating the quality of care it provides to oncology patients.
Alexandria, Va. – The American Society of Clinical Oncology (ASCO) released, “ASCO Principles for Patient-Centered Healthcare Reform,” seven recommendations designed to ensure access to high-quality cancer care amid the changing U.S. healthcare delivery landscape. The principles aim to assist the new Congress and Administration, so, as they consider the critical underpinnings of any healthcare reform proposal, the needs of patients facing a cancer diagnosis are met.
American Society of Clinical Oncology, Inc. (ASCO®) announced today that the Contemporary Oncology Team of Athens, Greece as part of the new international pilot project, is the first international practice to receive Quality Oncology Practice Initiative (QOPI®) certification through QOPI Certification Program, LLC (QCP).
The Senate has confirmed Monica M. Bertagnolli, MD, FACS, FASCO, as the 17th director of the National Institutes of Health (NIH). She served as president of the American Society of Clinical Oncology from 2018-2019 and is an accomplished cancer surgeon and researcher with deep expertise in community-based cancer research. While the director of the National Cancer Institute, Dr. Bertagnolli played a critical role in elevating the goals of the Cancer Moonshot initiative through the comprehensive National Cancer Plan and ASCO is excited to celebrate her new role leading the nation’s top federal medical research agency.
ALEXANDRIA, Va. — At the 2023 ASCO Quality Care Symposium, ASCO will recognize Deborah K. Mayer, PhD, RN, AOCN, FAAN, with the Joseph Simone Quality Care Award and Lecture, which recognizes visionary oncology care providers who excel in quality care. Dr. Mayer will be the first nurse to receive this award. On Friday, October 27, 2023, at 10:45 AM ET, she will receive the award and present her lecture, “Reflections on Improving Cancer Care: How Can We Do Better for Our Patients and Ourselves?” The meeting will be held in Boston, MA, and online from October 27-28, 2023.